Angiodysplasia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nikita Singh, M.B.B.S.[2]

Secondary Prevention

Secondary prevention aims to detect a disease earlier to allow timely intervention to reduce the impacts of the disease after it has already occurred.

For angiodysplasia, the role of vasoactive drugs in the prevention of acute bleeding events and beta blockers to reduce the mesenteric blood flow for secondary prophylaxis is still equivocal.^[1]

References

↑ Schwartz J, Rozenfeld V, Habot B (1992). “Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis–a case history”. Angiology. 43 (3 Pt 1): 244–8. doi:10.1177/000331979204300309. PMID 1575371.

Template:WS Template:WH

[pmid1575371-1] Schwartz J, Rozenfeld V, Habot B (1992). “Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis–a case history”. Angiology. 43 (3 Pt 1): 244–8. doi:10.1177/000331979204300309. PMID 1575371.

[1]